|Mr. Warren C. Lau||Chairman, CEO, CFO, Pres & Sec.||175k||N/A||64|
|Ms. Helen Stefanovic||Director of Regulatory Affairs||N/A||N/A||N/A|
Nexus BioPharma, Inc., a life science company, focuses on the development and commercialization of a pharmaceutical preparation to treat obesity and the symptoms of type 2 diabetes. The company is headquartered in Houston, Texas.
Nexus BioPharma, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.